VOLUME 60   1999   NUMBER 7

Brainstorms

425 Antipsychotic Polypharmacy, Part 1: Therapeutic Option or Dirty Little Secret? Stephen M. Stahl
[PDF]

ORIGINAL ARTICLES

427 The Economic Burden of Anxiety Disorders in the 1990s. Paul E. Greenberg, Tamar Sisitsky, Ronald C. Kessler, Stan N. Finkelstein, Ernst R. Berndt, Jonathan R. T. Davidson, James C. Ballenger, and Abby J. Fyer
[Abstract] [PDF]

436 Development of Depression During Placebo-Controlled Trials of Bupropion for Smoking Cessation: Case Reports. Christi A. Patten, Teresa A. Rummans, Ivana T. Croghan, Richard D. Hurt, and J. Taylor Hays
[Abstract] [PDF]

442 Open Trial of Flutamide for Treatment of Obsessive-Compulsive Disorder. Margaret Altemus, Benjamin D. Greenberg, David Keuler, Karen R. Jacobson, and Dennis L. Murphy
[Abstract] [PDF]

446 Mirtazapine in Major Depression With Comorbid Generalized Anxiety Disorder. Paul J. Goodnick, Alina Puig, C. Lindsay DeVane, and Blanche V. Freund
[Abstract] [PDF]

449 Measurement of Compliance With Naltrexone in the Treatment of Alcohol Dependence: Research and Clinical Implications. Kee Namkoong, Conor K. Farren, Patrick G. O'Connor, and Stephanie S. O'Malley
[Abstract] [PDF]

454 Self-Injurious Skin Picking: Clinical Characteristics and Comorbidity. Sabine Wilhelm, Nancy J. Keuthen, Thilo Deckersbach, Iris M. Engelhard, Amy E. Forker, Lee Baer, Richard L. O'Sullivan, and Michael A. Jenike
[Abstract] [PDF]

460 Late-Onset Adrenoleukodystrophy Associated With Long-Standing Psychiatric Symptoms. Sarah Garside, Patricia I. Rosebush, Anthony J. Levinson, and Michael F. Mazurek
[Abstract] [PDF]

469 A Pilot Study on Risperidone Metabolism: The Role of Cytochromes P450 2D6 and 3A. Jayme A. Bork, Thea Rogers, Peter J. Wedlund, and Jose de Leon
[Abstract] [PDF]

477 Clozapine Reduces Severe Self-Mutilation and Aggression in Psychotic Patients With Borderline Personality Disorder.  K. N. Roy Chengappa, Tom Ebeling, Jasbir S. Kang, Joseph Levine, and Haranath Parepally
[Abstract] [PDF]

CME Activity 491

492 Panic Disorder in the Primary Care Setting: Comorbidity, Disability, Service Utilization, and Treatment. Peter P. Roy-Byrne, Murray B. Stein, Joan Russo, Evelyn Mercier, Roxanne Thomas, John McQuaid, Wayne J. Katon, Michelle G. Craske, Alexander Bystritsky, and Cathy D. Sherbourne
[Abstract] [PDF]

LETTERS TO THE EDITOR

485 Effects of "Ecstasy" Blocked by Serotonin Reuptake Inhibitors. Dan J. Stein and Jeffrey Rink
[PDF]

485 Chorea and Tardive Dyskinesia in a Patient Taking Risperidone. Nancy B. Carroll, Kathryn E. Boehm, and R. Todd Strickland
[PDF]

487 Clozapine Versus Risperidone in Treatment-Refractory Schizophrenia: Possible Impact of Dosing Strategies. Hsien-Yuan Lane and Wen-Ho Chang
[PDF]

Book Reviews 489

Information for authors 502